Table 7 HGBI predicted drug-disease associations (top 10 in ranking list), and the corresponding evidence
From: Drug repositioning based on individual bi-random walks on a heterogeneous network
Drug | Disease | Evidence (PMID) | Rank |
|---|---|---|---|
Lithium | Conduct Disorder | 7491395;7691178;7751258 | 1 |
Lithium | Depressive Disorder | 27752079;2723135;21252007 | 2 |
Ertapenem | Pyelonephritis | 22563210 | 3 |
Moxifloxacin | Pyelonephritis | without evidence | 4 |
Gatifloxacin | Pyelonephritis | 11911553;15037328 | 5 |
Methotrexate | Psoriasis | 20178709;19626273;19323665 | 6 |
Levofloxacin | Pyelonephritis | without evidence | 7 |
Cefamandole | Staphylococcal Infections | 9419181 | 8 |
Cefprozil | Staphylococcal Infections | without evidence | 9 |
Vinblastine | Kidney Neoplasms | 8602639;11194540 | 10 |